Dassault Systèmes Share Falls 3.5% and Hits Resistance at 200-Day Moving Average of €20.80
The Vélizy-based 3D software publisher is consolidating at the close following a surge that propelled it up more than 14% in a week. The decline occurs within a notably bullish CAC 40, where the stock ranks among the worst performers. Technical indicators reflect profit-taking after a marked acceleration phase.
A 3.57% Decline Countering a CAC 40 Rise of More Than 1%
Dassault Systèmes shares are down 3.57% to €20.26, while the CAC 40 advances 1.03% to 8,495 points during the session. The stock thus ranks among the index's steepest declines, alongside Sanofi (-8.56%) and Capgemini (-4.01%), while Schneider Electric (+10.42%) and Bouygues (+7.24%) lead the market. The consolidation occurs following a gain of 14.08% for the week and 12.06% over one month, driven by the July 23rd publication and the announcement of the ArisGlobal acquisition for 1.8 billion dollars. Today's decline barely attenuates this weekly advance, without undermining the recent momentum. Over one year, the stock nevertheless remains down 31.74%, which underscores the magnitude of the decline suffered before the July rebound.
RSI at 71 and Move Below the 200-Day Moving Average, Profit-Taking After the Rally
At €20.26, the price remains above the 20-day moving average (€18.74) with a margin of 8.11%, and above the 50-day moving average (€18.69) by 8.40%, confirming a return to favorable near-term territory. Conversely, the stock has fallen below its 200-day moving average at €20.80 (margin -2.60%), a threshold that acted as a ceiling in the previous session at €21.01, an identified resistance level. The RSI at 71 reflects an overbought configuration following the recent surge, making today's pullback consistent with the magnitude of the move. Historically sensitive to the technology investment climate, the group also cited, during the Q2 2026 publication (July 23rd), geopolitical uncertainty and inflationary pressure among its risks, while highlighting growing cloud adoption and ArisGlobal integration as growth drivers in life sciences. The next technical benchmark to monitor remains the 200-day moving average at €20.80, whose breach will determine the continuation of the rebound.
